Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma

Abstract

Overexpression of cortactin is closely associated with poor human HCCs prognosis that caused by cancer embolus and metastasis. Cortactin and CTTN should be used for differentiating varieties of survival for patients after HCC resection.